Sarepta Therapeutics (SRPT) director receives 16,875 RSUs equity grant

Rhea-AI Filing Summary

Wigzell Hans Lennart Rudolf reported acquisition or exercise transactions in this Form 4 filing.

Sarepta Therapeutics director Hans Lennart Rudolf Wigzell reported a stock-based compensation grant. He was awarded 16,875 restricted stock units (RSUs), each representing one share of Sarepta common stock at no cash cost. The RSUs will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders that occurs at least 50 weeks after the prior year’s annual meeting. Following this award, Wigzell directly holds 42,098 shares of Sarepta common stock. This represents a routine equity compensation grant rather than an open-market share purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wigzell Hans Lennart Rudolf

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	16,875	$0.00	--

Holdings After Transaction: Common Stock — 42,098 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 16,875 RSUs Shares held after transaction: 42,098 shares Grant price per share: $0.00 per share +1 more

4 metrics

RSU grant size 16,875 RSUs Equity award to director Hans Wigzell

Shares held after transaction 42,098 shares Direct holdings following RSU grant

Grant price per share $0.00 per share RSU award cost to insider

RSU vesting period 1 year or next annual meeting Vests on earlier of one-year anniversary or qualifying annual meeting

Key Terms

restricted stock units ("RSUs"), annual meeting of stockholders, vest

3 terms

restricted stock units ("RSUs") financial

"The Reporting Person was granted restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

annual meeting of stockholders financial

"will vest on earlier of the one-year anniversary... and the next annual meeting of stockholders"

vest financial

"The RSUs will vest on earlier of the one-year anniversary of the date of grant"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wigzell Hans Lennart Rudolf

(Last) (First) (Middle)

215 FIRST STREET

SUITE 415

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sarepta Therapeutics, Inc. [ SRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		16,875	A	(1)	42,098	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting.

	/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Hans Wigzell	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Sarepta Therapeutics (SRPT) report for Hans Wigzell?

Sarepta reported that director Hans Lennart Rudolf Wigzell received 16,875 restricted stock units as an equity compensation grant. These RSUs are not an open-market purchase and were awarded at no cash cost to him.

How many Sarepta (SRPT) shares does Hans Wigzell hold after this Form 4 filing?

After the reported RSU grant, Hans Lennart Rudolf Wigzell directly holds 42,098 shares of Sarepta common stock. This figure includes the impact of the 16,875 restricted stock units reported in the filing.

What are the vesting terms of the Sarepta (SRPT) RSUs granted to Hans Wigzell?

The 16,875 RSUs granted to Hans Wigzell will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders that occurs at least 50 weeks after the prior year’s annual meeting.

Did Hans Wigzell buy or sell Sarepta (SRPT) shares on the open market?

The Form 4 does not show an open-market buy or sale. Instead, it reports a grant of 16,875 restricted stock units as compensation, with a transaction price per share of $0.00.

What does the transaction code "A" mean in the Sarepta (SRPT) Form 4?

The transaction code "A" in this Form 4 indicates a grant, award, or other acquisition of securities. In this case, it reflects the award of 16,875 restricted stock units to director Hans Wigzell as equity compensation.